Jing Mo
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 4
- Ophthalmology top 5%
- Retinal Diseases and Treatments 3
- Glaucoma and retinal disorders 3
- Ocular Oncology and Treatments 3
-
- RNA modifications and cancer 10
- RNA and protein synthesis mechanisms 6
- Genomics and Phylogenetic Studies 5
- Journals
- Nucleic Acids Research (3 papers)Frontiers in Marine Science (3 papers)BMC Ophthalmology (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jing Mo
54 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 298
- Ophthalmology 136
- Molecular Biology 634
- Oncology 160
- Immunology 91
Countries citing papers authored by Jing Mo
This map shows the geographic impact of Jing Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Mo more than expected).
Fields of papers citing papers by Jing Mo
This network shows the impact of papers produced by Jing Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Mo. The network helps show where Jing Mo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcriptionbreakdown → | 2024 | 99 |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 3 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 0 | |
| 13 | 2021 | 51 | |
| 14 | 2020 | 18 | |
| 15 | 2019 | 22 | |
| 16 | 2017 | 196 | |
| 17 | 2017 | 98 | |
| 18 | 2015 | 1 | |
| 19 | 2013 | 20 | |
| 20 | 2012 | 44 |
About Jing Mo
Jing Mo is a scholar working on Ophthalmology, Cancer Research and Molecular Biology, having authored 66 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), RNA and protein synthesis mechanisms (6 papers), Cancer-related molecular mechanisms research (6 papers), Genomics and Phylogenetic Studies (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Retinal Diseases and Treatments (3 papers), Glaucoma and retinal disorders (3 papers) and Ocular Oncology and Treatments (3 papers). The work is most often cited by research in Cancer Research (298 citations), Ophthalmology (136 citations) and Molecular Biology (634 citations). Jing Mo has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiang Zhou, Yuqi Chen, Tingting Hong, Tian Tian, Shaoru Wang, Xiulan Zhao, Wenbin Wei, Xueyi Dong, Xuefei Wang and Tao Sun. Their work appears in journals such as Nucleic Acids Research, Frontiers in Marine Science, BMC Ophthalmology, Scientific Reports and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.